vs
Side-by-side financial comparison of EQUITY BANCSHARES INC (EQBK) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
EQUITY BANCSHARES INC is the larger business by last-quarter revenue ($63.5M vs $60.1M, roughly 1.1× RHYTHM PHARMACEUTICALS, INC.). EQUITY BANCSHARES INC runs the higher net margin — 34.8% vs -92.6%, a 127.3% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (83.8% vs 28.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (43.8% CAGR vs 6.6%).
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
EQBK vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $63.5M | $60.1M |
| Net Profit | $22.1M | $-55.6M |
| Gross Margin | — | 88.1% |
| Operating Margin | 41.7% | -87.1% |
| Net Margin | 34.8% | -92.6% |
| Revenue YoY | 28.4% | 83.8% |
| Net Profit YoY | 30.0% | — |
| EPS (diluted) | $1.07 | $-0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $60.1M | ||
| Q4 25 | $63.5M | $57.3M | ||
| Q3 25 | $18.0M | $51.3M | ||
| Q2 25 | $58.4M | $48.5M | ||
| Q1 25 | $60.6M | $32.7M | ||
| Q4 24 | $58.3M | $41.8M | ||
| Q3 24 | $55.3M | $33.3M | ||
| Q2 24 | $55.4M | $29.1M |
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $22.1M | $-47.5M | ||
| Q3 25 | $-29.7M | $-52.9M | ||
| Q2 25 | $15.3M | $-46.6M | ||
| Q1 25 | $15.0M | $-49.5M | ||
| Q4 24 | $17.0M | $-43.3M | ||
| Q3 24 | $19.9M | $-43.6M | ||
| Q2 24 | $11.7M | $-32.3M |
| Q1 26 | — | 88.1% | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
| Q1 26 | — | -87.1% | ||
| Q4 25 | 41.7% | -82.2% | ||
| Q3 25 | -207.2% | -102.6% | ||
| Q2 25 | 31.5% | -93.4% | ||
| Q1 25 | 31.1% | -143.7% | ||
| Q4 24 | 35.0% | -98.6% | ||
| Q3 24 | 43.1% | -132.0% | ||
| Q2 24 | 29.4% | -139.2% |
| Q1 26 | — | -92.6% | ||
| Q4 25 | 34.8% | -83.0% | ||
| Q3 25 | -164.7% | -103.1% | ||
| Q2 25 | 26.1% | -96.1% | ||
| Q1 25 | 24.8% | -151.4% | ||
| Q4 24 | 29.1% | -103.6% | ||
| Q3 24 | 35.9% | -131.2% | ||
| Q2 24 | 21.1% | -110.9% |
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $1.07 | $-0.73 | ||
| Q3 25 | $-1.55 | $-0.82 | ||
| Q2 25 | $0.86 | $-0.75 | ||
| Q1 25 | $0.85 | $-0.81 | ||
| Q4 24 | $1.06 | $-0.71 | ||
| Q3 24 | $1.28 | $-0.73 | ||
| Q2 24 | $0.76 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $340.6M |
| Total DebtLower is stronger | $443.2M | — |
| Stockholders' EquityBook value | $732.1M | $122.9M |
| Total Assets | $6.4B | $442.3M |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $340.6M | ||
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M |
| Q1 26 | — | — | ||
| Q4 25 | $443.2M | — | ||
| Q3 25 | $486.9M | — | ||
| Q2 25 | $448.4M | — | ||
| Q1 25 | $376.9M | — | ||
| Q4 24 | $312.8M | — | ||
| Q3 24 | $437.5M | — | ||
| Q2 24 | $391.7M | — |
| Q1 26 | — | $122.9M | ||
| Q4 25 | $732.1M | $139.1M | ||
| Q3 25 | $711.9M | $148.8M | ||
| Q2 25 | $635.6M | $-11.9M | ||
| Q1 25 | $617.3M | $18.9M | ||
| Q4 24 | $592.9M | $21.7M | ||
| Q3 24 | $504.0M | $11.2M | ||
| Q2 24 | $461.4M | $39.3M |
| Q1 26 | — | $442.3M | ||
| Q4 25 | $6.4B | $480.2M | ||
| Q3 25 | $6.4B | $506.9M | ||
| Q2 25 | $5.4B | $372.7M | ||
| Q1 25 | $5.4B | $386.7M | ||
| Q4 24 | $5.3B | $392.3M | ||
| Q3 24 | $5.4B | $363.6M | ||
| Q2 24 | $5.2B | $381.8M |
| Q1 26 | — | — | ||
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.68× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 0.85× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $51.4M | — |
| Free Cash FlowOCF − Capex | $38.1M | — |
| FCF MarginFCF / Revenue | 60.0% | — |
| Capex IntensityCapex / Revenue | 20.9% | — |
| Cash ConversionOCF / Net Profit | 2.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $88.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $51.4M | $-25.4M | ||
| Q3 25 | $8.5M | $-26.6M | ||
| Q2 25 | $28.3M | $-23.3M | ||
| Q1 25 | $21.7M | $-40.4M | ||
| Q4 24 | $73.8M | $-18.8M | ||
| Q3 24 | $23.5M | $-25.2M | ||
| Q2 24 | $16.0M | $-29.1M |
| Q1 26 | — | — | ||
| Q4 25 | $38.1M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $26.0M | — | ||
| Q1 25 | $20.2M | — | ||
| Q4 24 | $65.4M | — | ||
| Q3 24 | $19.7M | — | ||
| Q2 24 | $15.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | 60.0% | — | ||
| Q3 25 | 24.7% | — | ||
| Q2 25 | 44.5% | — | ||
| Q1 25 | 33.3% | — | ||
| Q4 24 | 112.1% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 27.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 20.9% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 14.6% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 1.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 4.35× | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 1.37× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
